Last Updated: November 16, 2026

Patent: 9,603,739

« Back to Dashboard


Summary for Patent: 9,603,739
Title:Intraocular delivery devices and methods therefor
Abstract: Injection devices for delivering pharmaceutical compositions into the eye are described. Some devices include a resistance component for controllably deploying an injection needle through the eye wall. The resistance component may be disposed on the injector device, or on a portion of the injection device housing, or on a drug reservoir. Some devices may be removably attached to a drug reservoir, for example, through a luer connector. Other devices may comprise internal luer seal for securely connecting a drug conduit of the device to the luer cavity of a drug reservoir. Yet other devices may comprise a priming-enabling element to facilitate the drug priming of a shielded needle. Related methods and systems comprising the devices are also described.
Inventor(s): Lerner; Leonid E. (Corona Del Mar, CA)
Assignee: OcuJect, LLC (Newport Beach, CA)
Application Number:14/839,795
Patent Claims:see list of patent claims

Details for Patent 9,603,739

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genentech, Inc. AVASTIN bevacizumab Injection 125085 February 26, 2004 ⤷  Start Trial 2035-08-28
Genentech, Inc. LUCENTIS ranibizumab Injection 125156 June 30, 2006 ⤷  Start Trial 2035-08-28
Genentech, Inc. LUCENTIS ranibizumab Injection 125156 August 10, 2012 ⤷  Start Trial 2035-08-28
Genentech, Inc. LUCENTIS ranibizumab Injection 125156 October 13, 2016 ⤷  Start Trial 2035-08-28
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.